step 3 14 Flashcards
cardiovascular risk of SLE
significant risk factor for the development of premature coronary atherosclerosis and coronary artery disease in young women. Cardiovascular events are the leading cause of mortality in patients with SLE.
conservative measures to prevent acute otitis media
Cessation of smoking, continuation of breastfeeding, avoidance of day care, and discontinuation of pacifier use
primary complication of intussusception reduction
intestinal perforation (get radiograph)
tPA window
4.5 hours
target BP ranges in acute stroke
Target BP (Permissive HTN)
220, 180, 140
no tPA, tPA, hemorrhagic
CLL presentation
lymphadenopathy, organomegaly, and anemia/thrombocytopenia
fastest acting ace-i, also easy to titrate
enalapril
bad prognostic findings in CLL
anemia/thrombocytopenia
HSM
strep throat treatment duration
penicillin x 10 days
cocaine toxicity management
Benzodiazepines & nitroglycerin Beta blockers contraindicated CCBs for persistent chest pain Phentolamine for persistent hypertension ± PCI for myocardial infarction
hypercalcemia system
adjust for albumin → PTH + repeat calcium to confirm
mortality risk with elderly dementia patients
elevated
JME presentation
upper extremity morning myoclonus and subsequent generalized tonic-clonic seizures.
JME treatment
valproic acid
MMR contraindications
(LIVE)
Anaphylaxis to prior MMR vaccination, neomycin, or gelatin
Immunodeficiency (eg, HIV with CD4 <200/mm3, leukemia)
Pregnancy
standard composition for enteral feeds
30 kcal/kg/day and 1 g/kg/day of protein
transverse myelitis presentation
Rapidly progressive weakness of the lower extremities following an upper respiratory infection, accompanied by sensory loss and urinary retention.
bacterial conjunctivitis treatment
erythromycin ointment or polymyxin-trimethoprim drops. However, fluoroquinolones are preferred for contact wearers due to higher risk for pseudomonal infection
most common complication of bacterial conjunctivitis in patients who wear contacts
Keratitis, or inflammation of the cornea
comorbidity of all spina bifida
neurogenic bladder